Introduction: Adolescent/young adult (AYA) patients with metastatic soft tissue sarcoma (STS) typically face a dismal prognosis. However, a subset of patients with incurable disease lives beyond two years. Due to the rarity of diagnoses and inherent heterogeneity within this population, a paucity of data exists regarding the experiences of AYAs with an indolent course (and how to best capture these experiences). With increasing biological insight and clinical experience, including the use of targeted or immune therapies, it is anticipated that more such patients will experience prolonged survival. Our pilot study aimed to describe the clinical characteristics and illness experiences of AYAs with incurable yet indolent metastatic STS who were living two years after their diagnoses. Our exploratory aim was to generate a conceptual framework that could subsequently be tested in a multi-center study with a larger cohort of patients. Materials and Methods: Patients with metastatic incurable STS, aged 15–39 years at diagnosis, and at least two years from diagnosis, were eligible. Patients were recruited over a two-year period at a quaternary children’s hospital with a comprehensive AYA oncology program. Participants completed a demographic form and PROMIS short form questionnaires for seven domains and answered an open-ended question. Responses to open-ended questions were coded independently by two authors and utilized to generate themes. Clinical variables were collected from medical records. Results: Five patients completed questionnaires. Mean age was 29.4 years (18.5–39.8 years) at diagnosis and 34 years (23.2–45.7 years) at study. Three patients were female; two were male; four were White; and one was Black/African American. Diagnoses included ASPSCR1::TFE3 alveolar soft part sarcoma; WWTR1::CAMTA1 epithelioid hemangioendothelioma; INI-1 deficient epithelioid sarcoma; EWSR1::NR4A3 extra-skeletal myxoid chondrosarcoma; and low-grade ARHGAP23::FER spindle cell malignancy, a novel fusion-driven sarcoma. Mean time since diagnosis was 4.5 years (2.6–6 years), and mean treatment duration was 4.2 years (1.5–6 years). On average, patients received 4.8 lines (range 2–8 lines) of antineoplastic therapy. All patients received at least one targeted therapy or immune checkpoint inhibitor. Patients reported increased fatigue and anxiety and decreased physical function compared to the standardized US reference population. Themes emerging from qualitative responses included managing physical symptoms, navigating feelings of guilt and inadequacy, self-reflection generating gratitude, and changing illness experiences over time. Conclusions: AYA patients living with incurable metastatic soft tissue sarcoma for more than two years were treated with multiple lines of antineoplastic therapy longitudinally. PROMIS data identified fatigue, anxiety, and decreased physical function within this population. Exploratory thematic analysis of qualitative responses generated concepts that could be further tested in an expanded cohort of patients.
Research-based theater (RbT) in health care and medical education settings generates unique ethical discourses, particularly when involving pediatric patients. Ed’s Story: The Dragon Chronicles (Ed’s Story) is a verbatim play based on the journal of a teenaged oncology patient, and 25 interviews conducted after his death with his family and multidisciplinary health professional team. The development, dissemination, and evaluation of Ed’s Story will be retrospectively analyzed in order to highlight and discuss ethical tensions, with specific focus on tensions related to participants, including Ed and the interviewees; RbT practitioners and researchers; and audiences, namely, medical trainees who participated in mandatory curriculum viewing. Where applicable, similar projects described in the literature will be reviewed in order to highlight strategies to mitigate these tensions.
1 October 2024 in Journal of Adolescent and Young Adult Oncology
This cross-sectional study described prevalent body image (BI) concerns among adolescents and young adults (AYAs) with neoplasms who received treatment at a quaternary care children's hospital. Thirty-two AYAs, aged 15-39 years, completed questionnaires assessing BI within six months of diagnosis. The most frequently endorsed questionnaire items included the following: desire for increased physical fitness (62.5%), self-consciousness about hair (45.2%), weight dissatisfaction (40.6%), lack of strength (37.5%), wearing loose clothing to hide one's body (37.5%), decreased agility (34.4%), shape dissatisfaction (32.2%), and self-perception of too much body fat (31.3%). Awareness of AYA BI concerns during treatment may generate early intervention targeting this complex issue.
26 June 2026 in Journal of Adolescent and Young Adult Oncology
This cross-sectional study described oncofertility experiences of adolescent/young adult cancer survivors in Saskatchewan, Canada. Thirty-two AYAs (21.2 years, 56.3% male, 32.3% Indigenous) completed questionnaires. Medical records were reviewed. Distance to single centralized fertility clinic was calculated using geocoding software. 46.6% recalled oncofertility discussions, 35.5% had discussions documented, and 22.6% received fertility preservation referrals. Barriers included lack of available procedures and cost, but not travel. AYAs diagnosed ≤12 years were less likely to have FP referral ( p = 0.03). Sex, treatment-related infertility risk, and distance did not impact discussion or FP referral odds. These data will inform our provincial oncofertility algorithm.